Home
Scholarly Works
301 Optimizing the culture process of engineered t...
Conference

301 Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy

Authors

Carli C; Khuon M; Dahmani A; Bezverbnaya K; Bramson J; Delisle J

Volume

20

Pagination

pp. s102-s103

Publisher

Elsevier

Publication Date

May 1, 2018

DOI

10.1016/j.jcyt.2018.02.299

Conference proceedings

Cytotherapy

Issue

5

ISSN

1465-3249

Contact the Experts team